Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05796791 · ClinicalTrials.gov registry record · Early Phase 1
Ketamine and Motivational Enhancement Therapy for the Treatment of Tobacco Use Disorder
A Early Phase 1 study of Smoking Cessation and Tobacco Use, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 7
- Enrollment target
- 1
- Study location
NCT05796791 is a Early Phase 1 study of Smoking Cessation and Tobacco Use that has completed, run by Medical University of South Carolina. The registered enrollment target is 7 participants, below the 475-participant average among 188 other Smoking Cessation trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05796791, a Early Phase 1 study of Smoking Cessation and Tobacco Use, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 7 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to examine whether an investigational medication called ketamine is able to improve treatment outcomes for tobacco use disorder when delivered in conjunction with brief motivational enhancement therapy. Participants will receive ketamine assisted motivational enhancement therapy weekly for three weeks and there will be 2 follow up visits. All visits will also consist of questionnaires and saliva samples will be taken. The overall participation will last approximately 8 weeks.
Conditions Studied
Interventions
- DRUG Ketamine Hydrochloride
- BEHAVIORAL Motivational enhancement therapy
Study Locations (1)
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2023-05-02 |
| Est. Completion | 2024-06-30 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05796791
The ClinicalTrials.gov registry entry for NCT05796791 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 475-participant average among 188 other Smoking Cessation trials with a reported enrollment target (99% lower). The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Smoking Cessation appearing as the primary indexed condition, and to 2 interventions - of which Ketamine Hydrochloride is the first listed.
NCT05796791 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.
Frequently Asked Questions
What is clinical trial NCT05796791 about?
NCT05796791 is a clinical study titled "Ketamine and Motivational Enhancement Therapy for the Treatment of Tobacco Use Disorder". The purpose of the study is to examine whether an investigational medication called ketamine is able to improve treatment outcomes for tobacco use disorder when delivered in conjunction with brief motivational enhancement therapy. Participants will receive ketamine assisted motivational enhancement ...
What is the current status of trial NCT05796791?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 7 participants. The study started on 2023-05-02. Estimated completion is 2024-06-30.
What conditions does trial NCT05796791 study?
This clinical trial studies the following conditions: Smoking Cessation, Tobacco Use, Nicotine Dependence.
What interventions are being tested in trial NCT05796791?
The interventions under investigation include: Ketamine Hydrochloride (DRUG), Motivational enhancement therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT05796791?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05796791 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Smoking Cessation Intervention During Low Dose CT (LDCT) Screening for Lung Cancer
ACTIVE NOT RECRUITING · Early Phase 1
-
Smoking Cessation Treatment for Head & Neck Cancer Patients
ACTIVE NOT RECRUITING · Early Phase 1
-
End Nicotine Dependence Clinic
COMPLETED · Early Phase 1
-
Hollings Cancer Center Varenicline Sampling Study
COMPLETED · Early Phase 1
-
Applying mHealth to Tobacco-related Health Disparities
COMPLETED · Early Phase 1
-
Smoking by IV Pulsed Nicotine
COMPLETED · Early Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.